Fantastic to see such strong engagement at #NextGenBiomed2026! Jonathan Collins, took the stage to explore the future of large-scale microwave peptide synthesis and what it means for accelerating development and manufacturing. Thanks to everyone who joined us!

We’re pleased to share that our VP of Business Development, Jonathan Collins, will be speaking at #NextGenBiomed2026. His session covers advances in large-scale microwave peptide synthesis, improving efficiency and scalability from early R&D to cGMP production.

We’re excited to share that we’ll be exhibiting at #NextGenBiomed2026 in London on 24–25 March 2026! Visit Stand 2 and speak with our team to learn about our latest solutions in peptide synthesis, supporting your programs from early-stage R&D through to cGMP production scale. #NGB2026 #NextGenBiomed